XML 44 R34.htm IDEA: XBRL DOCUMENT v3.8.0.1
Overview and Basis of Presentation - Schedule of Cumulative Effects of New Revenue Standard on Income Statement (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Revenue $ 129,791 $ 93,888 [1]
Operating expenses:    
Sales and marketing [2] 65,058 46,269 [1]
Operating loss (33,615) (25,261) [1]
Net loss $ (29,325) $ (25,081) [1],[3],[4]
Net loss per share, basic and diluted (usd per share) $ (0.28) $ (0.26) [1]
As Previously Reported    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Revenue   $ 93,007
Operating expenses:    
Sales and marketing   47,301
Operating loss   (27,174)
Net loss   $ (26,994)
Net loss per share, basic and diluted (usd per share)   $ (0.28)
Adjustments | Accounting Standards Update 2014-09    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]    
Revenue   $ 881
Operating expenses:    
Sales and marketing   (1,032)
Operating loss   1,913
Net loss   $ 1,913
Net loss per share, basic and diluted (usd per share)   $ 0.02
[1] See Note 1 for a summary of adjustments.
[2] Includes share-based compensation expense as follows: Three Months EndedMarch 31,2018 2017 * As adjustedCost of revenue$3,098 $2,104Research and development10,231 6,914Sales and marketing8,007 5,524General and administrative5,652 4,562
[3] See Note 1 for a summary of adjustments.
[4] See Note 1 for a summary of adjustments.